I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
David Robert Moller, M.D.
Director, Sarcoidosis Clinic
Professor of Medicine
Expertise: Pulmonary Disease and Critical Care Medicine, Sarcoidosis
Research Interests: Pulmonary fibrosis; Sarcoidosis; Granulomatous lung disease
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
Dr. David Moller is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine, with a particular focus on sarcoidosis. Dr. Moller serves as the director of the Sarcoidosis Clinic at Johns Hopkins.
Dr. Moller earned his M.D. from the Tufts University School of Medicine. He completed his residency at the University of Cincinnati College of Medicine. He performed a fellowship in allergy and clinical immunology at the University of Cincinnati College of Medicine and a fellowship in pulmonary medicine at the National Institutes of Health.
Dr. Moller’s research interests include pulmonary fibrosis, sarcoidosis and granulomatous lung disease.
- Director, Sarcoidosis Clinic
- Professor of Medicine
- MD; Medicine, Tufts University School of Medicine (1979)
- University of Cincinnati College of Medicine / Occupational Medicine (1983)
- University of Cincinnati College of Medicine / Allergy and Clinical Immunology (1985)
- National Institutes of Health / Pulmonary Medicine (1989)
- American Board of Allergy and Immunology / Allergy & Immunology (1985)
- American Board of Internal Medicine / Internal Medicine (1982)
- American Board of Internal Medicine / Pulmonary Disease (1988)
Research & Publications
Dr. Moller’s research focuses on sarcoidosis. He was the senior investigator on a project that identified a possible protein trigger responsible for sarcoidosis, a potentially fatal inflammatory disease marked by tiny clumps of inflammatory cells that each year leave deep, grainy scars on the lungs, lymph nodes, skin and almost all major organs in hundreds of thousands of Americans.
He is currently coordinating two clinical trials at Johns Hopkins—one related to genomic research in sarcoidosis and one related to genomic research in Alpha-1 antitrypsin deficiency.
Selected PublicationsView all on Pubmed
Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, Zhang Y, O'Neal S, Senior RM, Becich M, Hochheiser HS, Kaminski N, Wisniewski SR, Gibson KF; GRADS Sarcoidosis Study Group. "Rationale and Design of the Genomic Research in alpha-1 antitrypsin deficiency and sarcoidosis (GRADS) study. Sarcoidosis Protocol." Ann Am Thorac Soc. 2015 Oct;12(10):1561-71. doi: 10.1513/AnnalsATS.201503-172OT.
Chen ES, Moller DR. "Etiologies of sarcoidosis." Clin Rev Allergy Immunol. 2015 Aug;49(1):6-18. doi: 10.1007/s12016-015-8481-z. PMID: 25771769
Moller DR. "Negative clinical trials in sarcoidosis: failed therapies or flawed study design?" Eur Respir J. 2014 Nov;44(5):1123-6. doi: 10.1183/09031936.00156314. No abstract available. PMID: 25362122
Chen ES, Moller DR. "Etiologic role of infectious agents." Semin Respir Crit Care Med. 2014 Jun;35(3):285-95. doi: 10.1055/s-0034-1376859. Epub 2014 Jul 9. Review. PMID: 25007081
Muller-Quernheim J, Prasse A, Moller DR. "Sarcoidosis: recent advances." Semin Respir Crit Care Med. 2014 Jun;35(3):283-4. doi: 10.1055/s-0034-1376864. Epub 2014 Jul 9. No abstract available.
Zhou T, Zhang W, Sweiss NJ, Chen ES, Moller DR, Knox KS, Ma SF, Wade MS, Noth I, Machado RF, Garcia JG. Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLoS One. 2012;7(9):e44818. doi: 10.1371/journal.pone.0044818. Epub 2012 Sep 12. PMID: 22984568
Brandstrup B, Svendsen PE, Rasmussen M, Belhage B, Rodt SA, Hansen B, Moller DR, Lundbech LB, Andersen N, Berg V, Thomassen N, Andersen ST, Simonsen L. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance? Br J Anaesth. 2012 Aug;109(2):191-9. doi: 10.1093/bja/aes163. Epub 2012 Jun 17. PMID: 22710266
Sweiss NJ, Zhang W, Franek BS, Kariuki SN, Moller DR, Patterson KC, Bennett P, Girijala LR, Nair V, Baughman RP, Garcia JG, Niewold TB. Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry. PLoS One. 2011;6(12):e29126. doi: 10.1371/journal.pone.0029126. Epub 2011 Dec 14. PMID: 22195005
Chen ES, Moller DR. Sarcoidosis--scientific progress and clinical challenges. Nat Rev Rheumatol. 2011 Jul 12;7(8):457-67. doi: 10.1038/nrrheum.2011.93. Review. PMID: 21750528
Videos & Media
Lectures and Presentations
Sarcoidosis: Advances in the Diagnosis and Treatment
Conference, 8th Annual Advances in the Treatment and Diagnosis of the Rheumatic Diseases (01/01/2012)
Recent News Articles and Media Coverage
“Ellicott City resident taps sports world to fight sarcoidosis,” The Baltimore Sun, Sept. 11, 2014